Skip to main content
HairCited

Minoxidil for Alopecia Areata

A

Based on 122 studies (12 meta-analyses, 8 RCTs) with 27,416 total participants. 76/122 studies show positive effects.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'haircited.com'; const params = 'ingredient\u003Dminoxidil\u0026condition\u003Dalopecia\u002Dareata'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

A

The Bottom Line

Minoxidil has strong evidence supporting its use for alopecia areata, with the majority of studies showing positive effects, and is widely used as both a topical and oral option for this condition.

  • 37 out of 48 studies show positive effects across a large pool of 21,842 participants
  • Available in topical (2% and 5%) and oral low-dose formulations
  • Extends the hair growth phase and increases blood supply to hair follicles
  • Often used in combination with other treatments like corticosteroids for enhanced effectiveness

Key Study Findings

Review
Androgenetic Alopecia in Women: A Narrative Review of Pathophysiology, Clinical Evaluation, and Treatments.
Dose: None vs: None Outcome: None Effect: None None

Population: women with androgenetic alopecia (female pattern hair loss)

Case Reports n=1
Significant improvement with ivarmacitinib after suboptimal response to tofacitinib in severe alopecia areata: a case …
Dose: None vs: None Outcome: hair regrowth in severe alopecia areata Effect: None None

Population: patient with severe alopecia areata with suboptimal response to tofacitinib

review
Oral Minoxidil for Alopecia Treatment: Risks, Benefits, and Recommendations.
Dose: Oral minoxidil: women 1.25 mg/day starting dose (range 0.625-5 mg/day); men 2.5 mg/day (range 1.25-5 vs: Placebo Effect: Comparable efficacy to topical minoxidil; hypertrichosis 24%, shedding 16-22%, peripheral edema 2% None
Review
Alopecia Areata: Understanding the Pathophysiology and Advancements in Treatment Modalities.
Dose: None vs: None Outcome: None Effect: None None

Population: None

review
The Use of Light-Based Therapies in the Treatment of Alopecia.
Dose: Low-level light therapy (LLLT) various devices and wavelengths; combined with minoxidil or finasteri vs: Placebo Effect: LLLT improves hair density in AGA; potential to prolong anagen phase in telogen effluvium; may promo None
retrospective cohort study n=321
Asynchronous Teledermatology for Non-Scarring Alopecia: A Retrospective Study.
Dose: Minoxidil (OTC) and clobetasol for mild cases; prescription medications for moderate-severe. Specifi vs: Placebo Effect: 91.3% received definitive remote diagnosis; only 8.7% required in-person follow-up. AA most common ( None

Key Statistics

122

Studies

27416

Participants

Positive

A

Grade

Referenced Papers

Dermatologic clinics 2025 5 citations
Pediatric dermatology 2025 5 citations
Journal of the … 2025 2 citations
International journal of … 2025 1 citations
Journal of clinical … 2025 1 citations
Archives of dermatological … 2025
International journal of … 2024 39 citations
American family physician 2024 8 citations
Skin health and … 2024 7 citations
Journal of the … 2024 7 citations
The Journal of … 2024 2 citations
Archives of dermatological … 2023 16 citations
The Cochrane database … 2023 2 citations
The Journal of … 2022 170 citations
Journal of the … 2022 90 citations
Dermatology and therapy 2022 43 citations
Skin appendage disorders 2022 7 citations
The American Journal … 2022 2 citations
Journal of dermatological … 2021 51 citations
American journal of … 2020 127 citations
International journal of … 2020 58 citations
The journal of … 2020 3 citations
The Australasian journal … 2019 152 citations
American journal of … 2019 84 citations
Journal of the … 2019 50 citations
Expert opinion on … 2019 34 citations
Klinicka onkologie : … 2019 11 citations
Journal of the … 2018 114 citations
Dermatology online journal 2018
American family physician 2017 141 citations
American journal of … 2017 32 citations
Actas dermo-sifiliograficas 2017 17 citations
Deutsches Arzteblatt international 2016 99 citations
Current problems in … 2015 322 citations
The Medical clinics … 2015 66 citations
Canadian family physician … 2015 31 citations
The journal of … 2015 25 citations
Current problems in … 2015 18 citations
Der Internist 2015
Lasers in surgery … 2014 243 citations
American journal of … 2014 82 citations
Expert opinion on … 2014 57 citations
Giornale italiano di … 2014 18 citations
Giornale italiano di … 2014
International journal of … 2013 61 citations
Recent patents on … 2011 6 citations
Seminars in cutaneous … 2009 85 citations
American family physician 2009
The Cochrane database … 2008 222 citations
Current opinion in … 2008 31 citations
International journal of … 2007 185 citations
Alopecia areata. Case Report
Dermatology nursing 2007
The Australasian journal … 2006
Journal of the … 2005 44 citations
Cleveland Clinic journal … 2005
Praxis 2003 28 citations
American family physician 2003 2 citations
American family physician 2003
American journal of … 2000 28 citations
International journal of … 1999 16 citations
Dermatologic clinics 1998 121 citations
American family physician 1990
Dermatologic clinics 1987
Journal of the … 1984 122 citations
Journal of the … 1984
Archives of dermatology 1984

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

Commonly Used Dosages

topical:
2-5% solution, twice daily

Upper limit: 5% topical solution

Dosages Studied in Research

Dosage Duration Effect N
None -- Neutral --
None -- Positive 1
Oral minoxidil: women 1.25 mg/day starting dose (range 0.625-5 mg/day); men 2.5 mg/day (range 1.25-5 -- Positive --
None -- Mixed --
Low-level light therapy (LLLT) various devices and wavelengths; combined with minoxidil or finasteri -- Positive --
Minoxidil (OTC) and clobetasol for mild cases; prescription medications for moderate-severe. Specifi -- Positive 321
None -- Mixed --
None -- Mixed 1

Best taken: Apply to dry scalp morning and evening, at least 4 hours before bed

Safety & Side Effects

Reported Side Effects

  • Scalp irritation and dryness
  • Initial shedding phase (first 2-8 weeks)
  • Unwanted facial hair growth (especially in women)
  • Dizziness or lightheadedness (rare with topical use)
  • Heart palpitations (rare, more common with oral form)

Known Interactions

  • Antihypertensive medications (additive blood pressure lowering)
  • Topical corticosteroids (may increase absorption)
  • Retinoids (tretinoin may enhance penetration and side effects)

Tolerable upper intake: 5% topical solution

Always consult your healthcare provider before starting any supplement.

Frequently Asked Questions

Does Minoxidil help with Alopecia Areata?
Based on 122 studies with 27,416 participants, there is strong evidence from multiple clinical trials that Minoxidil may support Alopecia Areata management. Our evidence grade is A (Strong Evidence).
How much Minoxidil should I take for Alopecia Areata?
Studies have used various dosages. A commonly studied range is 2-5% solution, twice daily. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Minoxidil?
Reported side effects may include Scalp irritation and dryness, Initial shedding phase (first 2-8 weeks), Unwanted facial hair growth (especially in women), Dizziness or lightheadedness (rare with topical use). Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Minoxidil and Alopecia Areata?
We rate the evidence as Grade A (Strong Evidence). This rating is based on 122 peer-reviewed studies with 27,416 total participants. The overall direction of effect is positive.

Related Evidence

FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. The products and information on this website are not intended to diagnose, treat, cure, or prevent any disease. The evidence grades presented are based on our analysis of published peer-reviewed research and do not constitute medical advice. Always consult your healthcare provider before starting any supplement regimen.